GSK Submits Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD Pharmaceutical Investing
Phase III IMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone Pharmaceutical Investing
Novel First-In-Class Immunotherapeutic APVO210 Features Unique Mechanism of Action Delivering IL-10 Biotech Investing
Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse Pharmaceutical Investing
RedHill Biopharma Announces New U.S. Patent for its Experimental Ebola Therapy Pharmaceutical Investing
Mesoblast Partners With Cartherics to Develop ’off-the-shelf’ Cell-based Immunotherapies for Solid Cancers Genetics Investing
“Avitas CBD Water, LLC” Rebranded As “Xanthic Beverages” and First Production to be Distributed to Over 500 Retail Locations Biotech Investing
